Alkalon is a privately-owned Specialty Pharma company focused on developing and commercializing medicated chewing gum formulations. The company is working in partnership with large pharmaceutical companies on dosage form development projects and has its own portfolio of nicotine gums approved for smoking cessation and smoking reduction. Alkalon’s in-house R&D activities take place in a small non-GMP laboratory and all non-core activities are outsourced.